Published in J Alzheimers Dis on January 01, 2014
Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS and NF-kB. J Cell Mol Med (2016) 0.84
A model for the induction of autism in the ecosystem of the human body: the anatomy of a modern pandemic? Microb Ecol Health Dis (2015) 0.81
Neurotoxicity by Synthetic Androgen Steroids: Oxidative Stress, Apoptosis, and Neuropathology: A Review. Curr Neuropharmacol (2015) 0.76
Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line. Endocrinology (2016) 0.76
Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer's disease. Alzheimers Res Ther (2015) 0.75
Reactive oxygen species: players in the cardiovascular effects of testosterone. Am J Physiol Regul Integr Comp Physiol (2015) 0.75
A comparative study of the effect of the dose and exposure duration of anabolic androgenic steroids on behavior, cholinergic regulation, and oxidative stress in rats. PLoS One (2017) 0.75
Alterations of the oxidative status in rat hippocampus and prodepressant effect of chronic testosterone enanthate administration. Mol Cell Biochem (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15
Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol (2003) 5.00
Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem (2004) 4.31
The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev (2002) 2.81
Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract (2006) 2.49
A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol (2010) 2.42
Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab (2007) 2.36
Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol (2008) 2.32
Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab (1991) 2.27
Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci (2000) 2.21
Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci (2003) 2.21
Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ (2000) 2.17
Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr (2005) 2.16
Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res (2007) 2.07
Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med (2013) 2.05
Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology (2001) 2.04
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism (1997) 1.97
Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab (1992) 1.94
Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc Natl Acad Sci U S A (1996) 1.79
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging (2003) 1.75
Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab (2010) 1.62
Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology (1995) 1.58
Diet and Alzheimer's disease. Curr Neurol Neurosci Rep (2007) 1.35
Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology (1996) 1.30
Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res (2001) 1.28
Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology (2005) 1.28
Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res (2002) 1.27
Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol (1998) 1.27
Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta (2006) 1.26
Androgen replacement therapy in the aging male--a critical evaluation. J Clin Endocrinol Metab (2001) 1.23
Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem (2004) 1.21
Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol Dis (2003) 1.17
Clinical review: Why is androgen replacement in males controversial? J Clin Endocrinol Metab (2010) 1.16
Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metab (2010) 1.13
A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male (2003) 1.13
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2009) 1.11
Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev (2008) 1.06
Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr (2001) 1.03
Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. Pharmacol Biochem Behav (2004) 1.02
Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc (2001) 1.02
Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Arch Neurol (2006) 1.01
Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells. Biomed Pharmacother (2001) 0.99
An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol (2000) 0.97
Testosterone replacement therapy in older adult men. Int J Androl (1999) 0.96
Increased Expression but Reduced Activity of Antioxidant Enzymes in Alzheimer's Disease. J Alzheimers Dis (1999) 0.96
Biomarkers of Alzheimer's disease among Mexican Americans. J Alzheimers Dis (2013) 0.95
Evidence for the role of luteinizing hormone in Alzheimer disease. Endocr Metab Immune Disord Drug Targets (2007) 0.95
Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. J Alzheimers Dis (2008) 0.95
Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta. Endocrinology (2009) 0.93
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res (2002) 0.93
Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels. J Clin Endocrinol Metab (2013) 0.92
Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis (2013) 0.92
Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol (1997) 0.91
Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. J Alzheimers Dis (2011) 0.90
Protective effects of black tea extract on testosterone induced oxidative damage in prostate. Cancer Lett (2005) 0.89
Trends in sex hormone concentrations in US males: 1988-1991 to 1999-2004. Int J Androl (2011) 0.88
Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into alpha-tubulin in a mouse neuroblastoma cell line. Arch Ital Biol (2006) 0.86
Testosterone effects on cognition in health and disease. Front Horm Res (2009) 0.84
Oxidative stress defines the neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells. Endocrinology (2013) 0.83
Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasma. Thromb Res (1995) 0.83
Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion. Horm Behav (2011) 0.81
Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J Clin Endocrinol Metab (1999) 0.76
Age-related patterns of urinary gonadotropins (FSH and LH) and E-3-G as measures of reproductive function among Turkana males of northern Kenya. Soc Biol (2011) 0.76